Investor's Business Daily on MSN

V2X Sees IBD RS Rating Climb To 74

V2X showed 60% EPS growth in its most recent report. Revenue gains came in at 1%. V2X holds the No. 33 rank among its peers ...
Vitamin D significantly affects IBD by influencing severity, inflammation, and patient outcomes. Optimizing vitamin D levels ...
A Relative Strength Rating upgrade for Teva Pharmaceutical ADR shows improving technical performance. Will it continue?
UBC offers a host of academic accommodations and has a network of alumni happy to share their tried and true strategies for ...
Please provide your email address to receive an email when new articles are posted on . Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn’s disease, presents a complex ...
People who have pro-inflammatory diets are up to three times more likely to have moderate-to-severe IBD, according to a new study.
Inflammatory bowel disease, in which the immune system attacks the gut, is a painful chronic condition that affects three million Americans. Rates of IBD are rising, and there’s currently no cure. IBD ...
GLP-1RA use, compared with basal insulin and DPP-4i use, was associated with lower risks for IBD and hospitalization in type 2 diabetes.
The Crohn’s & Colitis Foundation and an international consortium of leading IBD researchers, today announced the launch of the Global IBD Registry (GLIDE), a pioneering initiative designed to securely ...
Patients with IBD who undergo colorectal cancer surgery have a higher risk for venous thromboembolism within 1 year after ...